About This Investment Offer
It is our pleasure to invite you to become a shareholder of Good Mother Pharmaceuticals Group Australia Limited. Good Mother has been established to supply high-quality clinical grade vitamins and nutritional supplements to our neighbours in South-East Asia currently experiencing tremendous economic growth, starting with the Pearl of the Orient, The Philippines.
Compared to the Philippines’ top industry players, our business model places Good Mother at a distinct competitive advantage. Good Mother deviates from a tired, saturated and often infamous Pyramid or Multi-Level-Marketing model. Instead, Good Mother utilises a simplified entrepreneurial direct selling model for our brand representatives we call Wellness Managers.
Our Wellness Managers will focus on 2 distinctly Australian business practices – emphasis on high quality products and optimum level customer engagement experience. With 2,400 Wellness Managers already awaiting deployment, revenues will be quickly realised, hence accelerating returns to you as an investor. This is our competitive edge.
The pharmaceutical industry is a highly profitable sector where margins are generous. Good Mother gives you the opportunity to participate in this very lucrative industry. The cost of investment at inception is at its lowest with very strong growth potential from both dividend stream and capital gain perspectives.
Invitation for Investment
Join Good Mother in this opportunity for high-quality vitamins and nutritional supplements to hit the highly progressive South-East Asian health and wellness market.
Why Invest In Good Mother?
Economic Surge in South-East Asia
South-East Asia is poised as the next big market to show enormous growth following China and India. The journey begins in the Philippines. The Philippines is a progressive economy that has shown enormous growth in recent years and is projected by international independent observers, such as the World Bank, as having a strong positive economic outlook.
Robust Pharmaceutical Industry
Good Mother has a clear and unobstructed opportunity to enter the market with high-quality products that we are privileged to enjoy in Australia. There are very few competitors in the Philippines that may be able to compete with Good Mother based on product quality and integrity. By deviating from an expensive Multi-Level-Marketing scheme model, Good Mother is able to reach a large population and offer products at competitive prices without sacrificing product content and quality.
High Product Integrity Competitive Advantage
Where it comes to nutritional value, Good Mother triumphs over its competitors. Good Mother measures over and above the FDA Philippines’ Recommended Energy and Nutrition Intake (RENI) levels as the minimum acceptable level to be classified as a ‘drug’ product and not merely as a ‘food’ item. Most competing brands contain inadequate active ingredients and cannot be classified as a ‘drug’ product. Good Mother’s products are designed to contain high nutritional content that we are currently consuming in Australia.
Substantial Financial Returns
Good Mother projects to achieve market leadership within 4 years of operation in the Philippines. Good Mother anticipates entering a second South-East Asian market after 2 full years of operation in the Philippines. These key milestones place Good Mother in a clear path to successfully executing its Exit Strategy by Year 5 of a potential IPO to maximise shareholder return on investment.